SCHEMBL1724928

SCHEMBL1724928

COc1ncc(-c2noc(COC3CCNCC3)n2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.43
PLAT P00750 1/20 0.41
GPR119 Q8TDV5 2/20 0.40
MAPT P10636 6/20 0.38
MAPK14 Q16539 1/20 0.38
MAPK1 P28482 4/20 0.37
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
TSHR P16473 3/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
THRB P10828 1/20 0.36
REN P00797 1/20 0.36
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL612389 0.99 NAAA (0.42) NAAAPLATGPR119MAPTMAPK14
SCHEMBL3783681 0.81 GPR119 (0.54) NAAAGPR119MAPTALDH1A1KMT2A
SCHEMBL13186625 0.81 NAAA (0.42) NAAAGPR119MAPTMAPK1TSHR
SCHEMBL4528547 0.78 GPR119 (0.58) NAAAGPR119MAPTTSHRMEN1
SCHEMBL610359 0.77 GPR119 (0.54) NAAAGPR119MAPK1ALDH1A1KMT2A
SCHEMBL608951 0.77 GPR119 (0.72) GPR119ALDH1A1
SCHEMBL14640643 0.75 GPR119 (0.48) NAAAPLATGPR119MAPTTSHR
SCHEMBL14640645 0.75 NAAA (0.44) NAAAPLATGPR119MAPTMAPK1
SCHEMBL14640814 0.70 GPR119 (0.41) NAAAPLATGPR119MAPTMAPK1
SCHEMBL14640819 0.70 GPR119 (0.54) NAAAPLATGPR119MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406256-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103335-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed